LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
130 hedge funds and large institutions have $196M invested in Lumos Pharma, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
+4
Holders Change %
+3.17%
% of All Funds
2.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
43
Reduced
26
Closed
25
Calls
$6.83M
Puts
$3.24M
Net Calls
+$3.59M
Net Calls Change
-$6.72M
Top Buyers
1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$16.1M |
2 |
Millennium Management
New York
|
$19M |
3 |
RG
Redmile Group
San Francisco,
California
|
$17M |
4 |
ACA
Avoro Capital Advisors
New York
|
$6.45M |
5 |
BlackRock
New York
|
$18.8M |
Top Sellers
1 |
O
OrbiMed
New York
|
$0 |
2 |
CCI
Columbus Circle Investors
|
$0 |
3 |
MWNA
Marshall Wace North America
New York
|
$0 |
4 |
PP
PDT Partners
New York
|
$0 |
5 |
Point72 Asset Management
Stamford,
Connecticut
|
$0 |